Transite Cement Pipe — Johns-Manville

Product Description

Transite was a brand name for a fiber-cement composite pipe and board product manufactured by Johns-Manville Corporation from the 1930s through approximately 1980. The product was marketed and sold under the Transite name for use in a wide range of construction and industrial applications, including underground sewer and water distribution lines, flue and vent piping, heating and ventilation ductwork, and general conduit systems. Its combination of durability, corrosion resistance, and low cost made it a preferred choice among contractors, municipal engineers, and industrial facilities throughout the mid-twentieth century.

Johns-Manville was one of the largest asbestos products manufacturers in the United States during this period, and Transite was among its most widely distributed product lines. The material was installed in residential, commercial, and industrial construction projects across the country, as well as in schools, hospitals, government buildings, and military installations. Because of Transite’s long service life and widespread installation, the product remains present in the infrastructure of many older structures and utility systems that predate its discontinuation.

Johns-Manville ceased production of Transite and other asbestos-containing products as asbestos regulations tightened in the late 1970s and early 1980s. The company filed for Chapter 11 bankruptcy protection in 1982, driven in large part by mounting asbestos injury litigation, and ultimately established the Manville Personal Injury Settlement Trust to compensate workers and others harmed by exposure to its products.

Asbestos Content

Transite pipe and board products contained approximately 20 to 25 percent chrysotile asbestos by weight, bonded within a Portland cement matrix. Chrysotile, sometimes called white asbestos, is a serpentine-form fiber that was the most commercially prevalent form of asbestos used in industrial manufacturing throughout the twentieth century. It has been classified as a Group 1 human carcinogen by the International Agency for Research on Cancer (IARC) and is regulated as a hazardous material under the Asbestos Hazard Emergency Response Act (AHERA) and OSHA standards.

In Transite, the asbestos fibers functioned as a structural reinforcement agent, binding with cement to produce a rigid, lightweight, and heat-resistant composite. Although the fibers were encapsulated within the hardened cement matrix in undisturbed finished product, they were readily released during any activity that cut, abraded, drilled, sanded, or otherwise mechanically disrupted the material. Regulatory records and occupational health documentation confirm that such disturbances produce airborne chrysotile fibers at concentrations that can exceed permissible exposure limits established by OSHA.

How Workers Were Exposed

Workers across multiple skilled and unskilled trades encountered Transite at various stages of its lifecycle — during initial installation, later modification and repair, and ultimately during demolition or removal. The nature and duration of fiber exposure varied significantly by trade and task.

Plumbers and Pipefitters regularly cut, threaded, and fitted Transite pipe during underground and above-grade installations. Cutting operations using power saws or hand tools on asbestos-cement pipe generate sustained clouds of fine respirable dust. Workers performing these tasks, often in enclosed spaces or trenches with limited ventilation, faced repeated and prolonged fiber inhalation over the course of careers spanning decades.

Construction Laborers were frequently present at job sites where Transite pipe was being installed, unloaded, or cut, placing them in proximity to dust-generating tasks even when they were not performing the cutting themselves. Bystander exposure in construction environments is well documented in occupational health literature and regulatory guidance.

HVAC Duct Workers encountered Transite board and duct sections during the installation and maintenance of heating and ventilation systems. Fabricating duct sections from Transite board required cutting and fitting the material to specification, generating asbestos-containing dust in enclosed mechanical rooms, attics, and utility spaces.

Demolition Workers faced acute exposure risks when breaking out, removing, or disposing of Transite pipe and board during building renovation or teardown projects. Demolition activities can release large quantities of previously bound asbestos fibers in a short period of time. Under current OSHA and EPA regulations, Transite and other asbestos-cement materials are classified as regulated asbestos-containing material (RACM) requiring special handling and abatement procedures prior to demolition. Workers who performed such tasks before these regulations were in effect, or at job sites where regulations were not followed, may have sustained significant cumulative exposures.

The diseases most commonly associated with occupational asbestos exposure include mesothelioma, lung cancer, asbestosis, and other asbestos-related pulmonary conditions. These diseases characteristically have long latency periods — often 20 to 50 years between initial exposure and clinical diagnosis — meaning workers exposed to Transite during the product’s peak installation years of the 1940s through 1970s may be receiving diagnoses today.

Manville Personal Injury Settlement Trust

Johns-Manville’s bankruptcy reorganization, finalized in 1988, established the Manville Personal Injury Settlement Trust — one of the largest asbestos compensation trusts in United States history. The trust was created specifically to compensate individuals who sustained personal injury from exposure to asbestos-containing products manufactured or sold by Johns-Manville, including Transite cement pipe and board.

Transite is a named and recognized product within the trust’s claims documentation framework. Claimants who can establish qualifying exposure to Johns-Manville’s Transite product and who have received a confirmed diagnosis of an asbestos-related disease are eligible to file a claim with the Manville Trust.

Eligible claim categories recognized by the Manville Personal Injury Settlement Trust typically include:

  • Mesothelioma (pleural, peritoneal, and pericardial)
  • Lung cancer (with qualifying asbestos exposure history)
  • Asbestosis (confirmed by pulmonary function and imaging criteria)
  • Other asbestos-related conditions as defined by the trust’s claims evaluation criteria

Claimants are generally required to provide documentation of product-specific exposure, which may include employment records, union membership records, co-worker affidavits, job site records, or other evidence establishing contact with Transite or other Johns-Manville products. An asbestos attorney experienced in trust fund claims can assist in gathering and organizing this documentation.

Because Transite was installed across a broad range of construction environments over several decades, affected workers may also have claims against other parties in the asbestos products supply chain, including distributors, contractors, or manufacturers of companion products used at the same job sites. A qualified asbestos litigation attorney can evaluate the full scope of potential compensation sources based on a claimant’s individual work history and exposure record.

Workers or surviving family members who believe they may have been exposed to Transite should consult with an attorney who handles asbestos trust fund and litigation claims. Trust fund filing deadlines and statute of limitations provisions vary by state and claimant circumstance, making timely legal consultation important.